SRNE stock forecast
Our latest prediction for Sorrento Therapeutics, Inc.'s stock price was made on the Sept. 13, 2018 when the stock price was at 4.80$.
In the short term (2weeks), SRNE's stock price should outperform the market by 0.01%. During that period the price should oscillate between -8.09% and +9.52%.
In the medium term (3months), SRNE's stock price should outperform the market by 0.90%. During that period the price should oscillate between -16.78% and +25.90%.Get email alerts
Create a solid portfolio with SRNE
About Sorrento Therapeutics, Inc.
Sorrento Therapeutics, Inc. engages in the research, development and manufacture of biopharmaceutical products. It focuses on therapies to treat specific stages in the evolution of cancer, from elimination, to equilibrium and escape which include biosimilars, immuno-oncology antibodies, cellular therapy, cell internalizing antibodies, and antibody drug conjugates. The company was founded by Henry H. Ji in 2006 and is headquartered in San Diego, CA.
At the moment the company generates 35M USD in revenues.
On its last earning announcement, the company reported a loss of -0.80$ per share.
The book value per share is 2.18$
Three months stock forecastSept. 13, 2018
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|